Aceragen Inc (ACGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACGN | AZN | AMGN | GILD | VRTX |
| Company | Aceragen Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4330 | 190.33 | 368.27 | 143.50 | 455.59 |
| High | 0.4411 | 195.79 | 378.82 | 146.92 | 461.26 |
| Low | 0.3800 | 189.35 | 366.53 | 143.49 | 450.78 |
| Latest | 0.3800 | 194.95 | 376.97 | 146.63 | 460.87 |
| Change | -0.0610 | +0.73 | +7.44 | +2.70 | +4.18 |
| % Change | -13.83% | +0.38% | +2.01% | +1.88% | +0.92% |
| Volume | 53,000 | 1,875,000 | 2,720,100 | 5,210,500 | 1,179,800 |
| 20-Day Average Volume | 203,340 | 2,278,035 | 2,690,920 | 7,473,025 | 1,454,725 |
| Previous Close | 0.4410 | 194.22 | 369.53 | 143.93 | 456.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6048 | 202.53 | 375.80 | 149.56 | 474.54 |
| 20-Day Raw Stochastic | 3.11% | 30.76% | 52.72% | 26.58% | 19.17% |
| 20-Day Relative Strength | 28.34 | 48.88 | 57.01 | 54.59 | 47.22 |
| Weighted Alpha | -94.15 | +31.12 | +28.96 | +38.44 | -2.73 |
| Today's Opinion | 100% Sell | 80% Buy | 100% Buy | 88% Buy | 64% Buy |
| Previous Opinion | 100% Sell | 80% Buy | 88% Buy | 88% Buy | 64% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.38% since 08/14/23 | -4.31% since 03/02/26 | -2.26% since 03/02/26 | -2.27% since 03/02/26 | -5.18% since 03/02/26 |
| Low | 0.3601 on 08/18/23 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 0.4770 on 08/17/23 | 203.29 on 03/04/26 | 381.74 on 03/03/26 | 148.92 on 03/04/26 | 484.10 on 03/03/26 |
| 1-Month | |||||
| %Chg | -61.23% since 07/21/23 | +3.69% since 02/09/26 | +0.31% since 02/09/26 | -3.33% since 02/09/26 | -2.12% since 02/09/26 |
| Low | 0.3601 on 08/18/23 | 189.35 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 1.0100 on 07/24/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 3-Month | |||||
| %Chg | -77.38% since 05/19/23 | +8.52% since 12/09/25 | +20.11% since 12/09/25 | +22.85% since 12/09/25 | +5.46% since 12/09/25 |
| Low | 0.3601 on 08/18/23 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 1.8765 on 06/16/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 6-Month | |||||
| %Chg | -92.29% since 02/21/23 | +20.01% since 09/09/25 | +34.65% since 09/09/25 | +26.67% since 09/09/25 | +16.24% since 09/09/25 |
| Low | 0.3601 on 08/18/23 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 5.3700 on 05/03/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,201 | 301,217,344 | 199,201,792 | 178,677,728 | 116,014,792 |
| Shares Outstanding, K | 8,424 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 4,860,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -23,360,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 2,470,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -21,870,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 1.14 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.94 on 06/29/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 07/04/24 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.56 | 16.82 | 17.81 | 28.06 |